🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This research is being done to study the safety and feasibility of implanti...
Status
Recruiting
Location
Dana-Farber Cancer Institute
Start Date
2024-12-01
Trial ID
NCT05700461
Treatments Being Tested
The purpose of the study is to evaluate if postoperative antibiotic use in ...
Status
Terminated
Location
Memorial Hermann Hospital
Start Date
2020-10-01
Trial ID
NCT04198129
This retrospective database study will assess differences in the risk of re...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01381458
This study is designed to determine if different doses of buprenorphine (ei...
Status
Terminated
Location
Erie County Medical Center
Start Date
2007-10
Trial ID
NCT00552578
Treatments Being Tested
The main objective of this study is to assess safety, tolerability, and pha...
Status
Completed
Location
The University of Chicago Medical Center /ID# 217196
Start Date
2020-01-22
Trial ID
NCT04196283
Treatments Being Tested
In this study, the investigator aims to identify the threshold of food resi...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-11-01
Trial ID
NCT07278076
Treatments Being Tested
The goal of this clinical study is to provide continued access to the study...
Status
Recruiting
Location
Helios Salud
Start Date
2024-08-27
Trial ID
NCT06337032
Treatments Being Tested
This is a Phase Ib/II, open-label, multicenter, randomized umbrella study i...
Status
Recruiting
Location
UC Irvine Medical Center
Start Date
2020-11-01
Trial ID
NCT04524871
retrospective non-interventional study (NIS) that aims to describe the demo...
Status
Completed
Location
Hamad Medical Corporation
Start Date
2021-09-13
Trial ID
NCT04916509
Treatments Being Tested
Dolutegravir (DTG) and lamivudine (3TC) are indicated in combination with o...
Status
Completed
Location
GSK Investigational Site
Start Date
2016-05
Trial ID
NCT02738931